D. E. Shaw & Co., Inc. Kiniksa Pharmaceuticals, Ltd. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $1.46 Million - $1.8 Million	-82,752 Reduced 27.17%	221,853 $4.38 Million
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $185,574 - $246,269	-12,914 Reduced 4.07%	304,605 $5.34 Million
Q3 2023 Nov 14, 2023	BUY	$13.62 - $20.2 $1.07 Million - $1.59 Million	78,919 Added 33.08%	317,519 $5.52 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $12,402 - $19,578	-1,188 Reduced 0.5%	238,600 $3.36 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $25,070 - $36,995	2,343 Added 0.99%	239,788 $2.58 Million
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $1.43 Million - $2.14 Million	125,274 Added 111.68%	237,445 $3.56 Million
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $675,811 - $928,548	69,243 Added 161.3%	112,171 $1.44 Million
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $326,252 - $489,808	42,928 New	42,928 $416,000
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $114,548 - $152,361	-12,317 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $127,973 - $186,602	12,317 New	12,317 $145,000
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $835,484 - $1.2 Million	-50,089 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$14.8 - $21.15 $773,995 - $1.11 Million	-52,297 Reduced 51.08%	50,089 $885,000
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $806,190 - $1.35 Million	53,004 Added 107.33%	102,386 $1.57 Million
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $744,680 - $1.28 Million	49,382 New	49,382 $1.26 Million
Q3 2019 Nov 14, 2019	SELL	$8.15 - $15.88 $212,992 - $415,007	-26,134 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$13.2 - $20.39 $912,410 - $1.41 Million	-69,122 Reduced 72.56%	26,134 $354,000
Q1 2019 May 15, 2019	BUY	$15.93 - $26.59 $1.37 Million - $2.28 Million	85,714 Added 898.28%	95,256 $1.72 Million
Q4 2018 Feb 14, 2019	BUY	$16.25 - $28.09 $155,057 - $268,034	9,542 New	9,542 $268,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.89M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$38.5 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$5.14 Million
2.82% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$1 Million
0.0% of portfolio
Barclays PLC London, X0

34.8K
Shares

$883,865
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$761,100
0.56% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $875M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account